Repurposed Drug Improves Outcomes for Patients With Severe COVID-19 Pneumonia
July 17, 2024
July 17, 2024
LONDON, England, July 17 (TNSres) -- The University College London issued the following news:
* * *
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCL, UCLH and the Francis Crick Institute.
* * *
The study, published in eLife, found that the drug dornase alfa reduced hyper- . . .
* * *
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCL, UCLH and the Francis Crick Institute.
* * *
The study, published in eLife, found that the drug dornase alfa reduced hyper- . . .